BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 8721615)

  • 21. The role of oxidized low density lipoprotein in atherogenesis.
    Jialal I; Devaraj S
    J Nutr; 1996 Apr; 126(4 Suppl):1053S-7S. PubMed ID: 8642431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
    Navab M; Ananthramaiah GM; Reddy ST; Van Lenten BJ; Ansell BJ; Fonarow GC; Vahabzadeh K; Hama S; Hough G; Kamranpour N; Berliner JA; Lusis AJ; Fogelman AM
    J Lipid Res; 2004 Jun; 45(6):993-1007. PubMed ID: 15060092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights.
    Rubbo H; O'Donnell V
    Toxicology; 2005 Mar; 208(2):305-17. PubMed ID: 15691594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein modification: cellular mechanisms.
    Chait A; Heinecke JW
    Curr Opin Lipidol; 1994 Oct; 5(5):365-70. PubMed ID: 7858911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
    Aviram M
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences.
    Francis GA
    Biochim Biophys Acta; 2000 Jan; 1483(2):217-35. PubMed ID: 10634938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis.
    Heinecke JW
    Atherosclerosis; 1998 Nov; 141(1):1-15. PubMed ID: 9863534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavonoids protect LDL from oxidation and attenuate atherosclerosis.
    Fuhrman B; Aviram M
    Curr Opin Lipidol; 2001 Feb; 12(1):41-8. PubMed ID: 11176202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of oxidation of lipoproteins in the pathogenesis of atherosclerosis].
    Picard S
    Pathol Biol (Paris); 1996 Jan; 44(1):46-50. PubMed ID: 8734300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidants and antioxidants in atherosclerosis.
    Mashima R; Witting PK; Stocker R
    Curr Opin Lipidol; 2001 Aug; 12(4):411-8. PubMed ID: 11507326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary antioxidants and cardioprotection--fact or fallacy?
    Steinbrecher UP
    Can J Physiol Pharmacol; 1997 Mar; 75(3):228-33. PubMed ID: 9164706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.
    Tertov VV; Kaplun VV; Orekhov AN
    Mol Cell Biochem; 1998 Jun; 183(1-2):141-6. PubMed ID: 9655188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The oxidative modification hypothesis of atherogenesis: an overview.
    Chisolm GM; Steinberg D
    Free Radic Biol Med; 2000 Jun; 28(12):1815-26. PubMed ID: 10946223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidants, dietary fat saturation, lipoprotein oxidation and atherogenesis.
    Schwenke DC
    Nutrition; 1996 May; 12(5):377-9. PubMed ID: 8875526
    [No Abstract]   [Full Text] [Related]  

  • 35. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis.
    Heinecke JW
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1261-4. PubMed ID: 11498450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidized LDL and atherogenesis.
    Ylä-Herttuala S
    Ann N Y Acad Sci; 1999 Jun; 874():134-7. PubMed ID: 10415527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
    Hazen SL; Heinecke JW
    J Clin Invest; 1997 May; 99(9):2075-81. PubMed ID: 9151778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of dacron-activated monocytic cell oxidation of low density lipoprotein.
    van Aalst JA; Pitsch RJ; Absood A; Fox PL; Graham LM
    J Vasc Surg; 2000 Jan; 31(1 Pt 1):171-80. PubMed ID: 10642720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidation of lipoproteins and atherosclerosis.
    Luc G; Fruchart JC
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection.
    Carr AC; McCall MR; Frei B
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1716-23. PubMed ID: 10894808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.